Martingale Asset Management trimmed its stake in Regeneron Pharmaceuticals by 6.9% last quarter, selling off 1,503 shares.

A federal judge tossed a lawsuit accusing Bristol Myers of monopolizing the blood cancer drug Pomalyst using shady patent ...

NPPA revises ceiling price of diagnostic agent following DoP's review order: Gireesh Babu, New Delhi Monday, April 14, 2025, 08:00 Hrs [IST] The National Pharmaceutical Pricing Au ...

A federal judge in New York has dismissed a proposed class action against pharmaceutical giant Bristol Myers Squibb, which ...

A group of lawmakers have come together to flip the board on an economy they say is controlled by monopolies, where a few ...

Last November’s election ushered in a new administration, a new Congress, and a new political agenda. One of the Trump ...

Explore the impact of Trump's tariffs on US financial markets, especially on tech giants like AAPL, GOOGL & AMZN. Read my ...

Pharma giant dodges threat as US judge dismisses monopoly claims over its blockbuster cancer drug | FDA approves new ...

China - Interpretation Of The Anti-Monopoly Guidelines For Pharmaceutical Sector: Key Risk Considerations. Legal News and ...

The FDA approved the use of Opdivo with Yervoy in front-line colorectal cancer, while a Manhattan court junked a class action ...